Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$48.70
-1.54%
Mkt Cap $2.87B
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (10 analysts)
$62.00
Range $55.00 – $65.00
Implied Upside
+27.3%
Consensus $62.00 vs current $48.70